Latest Breaking News On - European commission for pedmarqsi - Page 1 : comparemela.com

StockWatch: Regeneron s All Ears for Hearing Loss Drug Developer

StockWatch: Regeneron s All Ears for Hearing Loss Drug Developer
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoGrand viewUnited kingdomEli lillySteven barnardAlex aravanisLaurencee reidKorro bioJoseph pantginisJackk allenAstellas pharmaPhil febboEuropean commission for pedmarqsiCare researchUs bankruptcy court

Fennec Pharmaceuticals Announces European Commission Marketing Authorization for Pedmarqsi (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients

06.06.2023 - Pedmarqsi is the First and Only Approved Therapy in the European Union for Reducing the Risk of Cisplatin-induced Hearing Loss (Ototoxicity) in Pediatric Patients with Localized, Non-metastatic Solid TumorsRESEARCH TRIANGLE PARK, N.C., June 06, . Seite 1

Rosty raykovDrug administrationEuropean commissionCommittee for medicinal products human useEuropean commission for pedmarqsiEuropean unionFennec pharmaceuticalsClinical oncology group protocolMedicinal productsHuman useClinical oncology group